DONATE TODAY
To Increase Patient Access
SHOW POST CATEGORIESSHOW ALL POSTS

Post Category: Brain Cancer

February 3, 2026
Michelle's Story of HOPE

Michelle’s Story of Hope shares an inspiring brain cancer journey, support resources, and advocacy through the End Brain Cancer Initiative.

Read More
January 7, 2026
Exvade Monorail Device

Discover the Exvade Monorail Device, an FDA Breakthrough technology for real-time glioblastoma tracking. Learn about the clinical trial.

Read More
October 9, 2025
New Treatment Approved in Europe

The European Commission has approved VORANIGO (vorasidenib) for IDH-mutant gliomas, representing a significant advancement in targeted brain cancer therapy.

Read More
September 18, 2025
Importance of IDH1/IDH2 Mutations

Testing for IDH1/IDH2 mutations helps doctors accurately diagnose certain types of brain tumors, particularly gliomas.

Read More
September 5, 2025
Remembering Patrick O'Donnell

Patrick O’Donnell, recipient of the 2024 National HOPE Award has passed away at the age of 23 after a three-year battle with brain cancer.

Read More
September 2, 2025
First Pediatric Brain Cancer Treatment

Jazz Pharmaceuticals has announced the U.S. FDA's approval of Modeyso™ (dordaviprone), the first and only treatment for pediatric brain cancer.

Read More
August 28, 2025
Discounted Medications for Brain Cancer

Mark Cuban's Cost Plus Drug Company offers select brain cancer generic medications at a discounted price when compared to traditional pharmaceutical pricing.

Read More
June 3, 2025
PCNSL Clinical Trial

Explore a Phase 2 clinical trial for Primary Central Nervous System Lymphoma (PCNSL). Learn about eligibility and enrollment details at EndBrainCancer.org.

Read More
May 8, 2025
Optune Gio Tips

Top tips for wearing the Optune Gio device from a GBM brain cancer patient.

Read More
April 24, 2025
Tumor Treating Fields

What are Tumor Treating Fields and how are they used to treat GBM Brain cancer?

Read More
February 18, 2025
Know All Your Treatment Options 2025

Discover brain cancer treatment options for 2025. Learn about clinical trials, personalized medicine, and patient advocacy from the End Brain Cancer Initiative.

Read More
January 9, 2025
Expanded Access to Gallium Maltolate (GaM)

The Musella Foundation has funding for patients wanting to enroll in the Expanded Access Program (EAP) for Gallium Maltolate (GaM) for recurrent Glioblastoma.

Read More

ENDBRAINCANCER INITIATIVE | CHRIS ELLIOTT FUND

Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
DONATE
envelopephonemap-markerpointer-right
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram